Showing 281-290 of 300 results for "".
- Analysts Believe M&A Activity in the Pharmaceutical Sector Could Rise in 2019https://modernod.com/news/analysts-believe-ma-activity-in-the-pharmaceutical-sector-could-rise-in-2019/2476194/Analysts and investors hinted that M&A activity among drugmakers could increase in 2019 compared to the prior year, Business Insider reported
- Oklahoma Neonatologist-Researcher Earns NIH Grant to Advance Retinopathy of Prematurityhttps://modernod.com/news/oklahoma-neonatologist-researcher-earns-nih-grant-to-advance-retinopathy-of-prematurity/2482537/Faizah Bhatti, MD, was the first to discover the presence of surfactant protein A in the eye–a key protein related to blood vessel growth and previously believed to only exist in the lung. Now, the University of Oklahoma neonatologist and researcher has earned a 5-year, $2.3 million grant f
- Richard Rosen, MD, Receives Founders Award From ASRShttps://modernod.com/news/richard-rosen-md-receives-founders-award-from-asrs/2482366/The American Society of Retina Specialists (ASRS) is honoring Richard B. Rosen, MD, ScD (hon), FACS, FASRS, FARVO, CRA, the Belinda Bingham Pierce and Gerald G. Pierce Distinguished Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai, with
- RSC Survey Shows Travelers Relying on Glasses and Contact Lenses Have Vacation FOMOhttps://modernod.com/news/rsc-survey-shows-travelers-relying-on-glasses-and-contact-lenses-have-vacation-fomo/2481887/A new poll commissioned by the Refractive Surgery Council (RSC) reveals 50% of Americans with vision prescriptions missed out on at least one activity from their vacation because they wear glasses or contacts. As a result of their ‘vacation FOMO,’ 55% believe having vision c
- UC Irvine Researchers Discover a Nanobody that May Lead to Treatment for Retinitis Pigmentosahttps://modernod.com/news/uc-irvine-researchers-discover-a-nanobody-which-may-lead-to-treatment-for-retinitis-pigmentosa/2481805/A team of scientists from the University of California, Irvine, believe they have discovered a special antibody which may lead to a treatment for retinitis pigmentosa. The study,
- Medical Consulting Group and Corcoran Consulting Group Finalize Merger Agreementhttps://modernod.com/news/medical-consulting-group-and-corcoran-consulting-group-finalize-merger-agreement/2481723/Medical Consulting Group (MCG) and Corcoran Consulting Group (CCG) have finalized their merger that was announced in April. Financial terms of the deal were not disclosed. MCG and CCG stated they believe this merger will enhance the ophthalmic community by providing
- Aurion Biotech Receives Approval in Japan for First Allogeneic Cell Therapy to Treat Corneal Endothelial Diseasehttps://modernod.com/news/aurion-biotech-receives-approval-in-japan-for-first-allogeneic-cell-therapy-to-treat-corneal-endothelial-disease/2481486/Aurion Biotech announced it has received regulatory approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for its novel cell therapy, Vyznova, for the treatment of bullous keratopathy of the cornea. The company believes this is the first regulatory approval in the world fo
- Viridian Announces Positive Data from Ongoing Phase 1/2 Trial Evaluating Low Dose VRDN-001 in Patients with Thyroid Eye Disease (TED)https://modernod.com/news/viridian-announces-positive-data-from-ongoing-phase-12-trial-evaluating-low-dose-vrdn-001-in-patients-with-thyroid-eye-disease-ted/2481334/Viridian Therapeutics announced positive topline clinical data from the third, low dose cohort in its ongoing phase 1/2 clinical trial of VRDN-001, an anti-insulin-like growth factor 1 receptor (IGF-1R) antibody, in patients with active thyroid eye disease (TED). The company said it believes
- Pfizer CEO Predicts Third COVID-19 Vaccine Booster “Likely” Needed Within Yearhttps://modernod.com/news/pfizer-ceo-predicts-third-covid-19-vaccine-booster-likely-needed-within-year/2479086/Pfizer CEO Albert Bourla believes it will probably be necessary for people to receive yet another dose of COVID-19 vaccine within a year of being fully vaccinated in order to stave off infection, according to recent taped comments that were made public on Thursday. “There will be likely a n
- New Study Links Protein Causing Alzheimer’s Disease With Common Sight Losshttps://modernod.com/news/new-study-links-protein-causing-alzheimers-disease-with-common-sight-loss/2478957/Newly published research has revealed a close link between proteins associated with Alzheimer’s disease and age-related sight loss. The findings could open the way to new treatments for patients with deteriorating vision and through this study, scientists believe they could reduce the need for us